ArticlePolymers2026
New Polycationic Arabinogalactan Derivatives with the CHPTAC System: Structure, Properties and Antioxidant Activity.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cationic arabinogalactan (AG) derivatives with a degree of substitution (0.02-0.19) containing quaternary ammonium groups were prepared by reaction of the etherification of (3-Chloro-2-hydroxypropyl)-trimethylammonium chloride (CHPTAC), catalyzed by an aqueous solution of sodium hydroxide. The effect of etherification was assessed by the degree of substitution (DS). The DS values of the AG samples were controlled by the varied pH of the reaction mixture from 10 to 12 and the duration of the process quaternization (2, 18, 24, 30 and 72 h). In comparison, the quaternized samples of the AG were characterized by physicochemical research methods, such as elemental analysis, gel permeation chromatography (GPC), Fourier Transform Infrared (FTIR), and
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.